A detailed history of Orion Investment CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Orion Investment CO holds 462 shares of LLY stock, worth $384,171. This represents 0.17% of its overall portfolio holdings.

Number of Shares
462
Holding current value
$384,171
% of portfolio
0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $334,889 - $419,976
462 New
462 $418 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $790B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Orion Investment CO Portfolio

Follow Orion Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Orion Investment CO with notifications on news.